Neurovascular disorders or diseases refer to abnormality associated with blood vessels supplying blood to the brain and spine. This includes narrowing of arteries, which reduces blood flow to the brain and increases the risk of stroke (particularly “ischemic” stroke), and weakening of arteries, which may create brain aneurysms and increases the risk of intracranial bleeding (or “hemorrhagic” stroke). Neurovascular intervention deals with the diagnosis, treatment, and prevention of vascular disorders affecting the central nervous system (brain and spine). Neurovascular intervention mainly addresses two major disease areas, which are broadly defined as hemorrhagic stroke and ischemic stroke.
Growth of global neurovascular intervention market is driven by the rising prevalence of cerebrovascular diseases, higher incidences of neurological disorders, favorable reimbursement policies and expanding healthcare infrastructure. However, the market faces several challenges such as high treatment cost, multiple products recalls, dearth of skilled neurosurgeons and social stigma. The market is characterized by leading trends such as growth in mergers & acquisition activities, Technological advancement and use of minimally invasive techniques.
The report “Global Neurovascular Intervention Market – Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market with coverage on major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System. Future forecasts of neurovascular intervention overall and across various sub-segments until 2025 is provided in the report. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major international industry players operating in the global neurovascular intervention market include Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.
Key Factors Impacting Market Growth:
- Rising prevalence of cerebrovascular diseases
- Growing favorable reimbursement policies and expanding healthcare infrastructure
North America, Western Europe, and Asia Pacific by region are estimated to dominate the neurovascular intervention market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for neurovascular intervention market during the forecast period.
The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for neurovascular intervention market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for neurovascular intervention market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for neurovascular intervention during the forecast period.
Companies Covered: Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation
- Cerebral Thrombectomy Devices
- Flow Diverter for Aneurysm
- Carotid Artery Stenting (CAS)
- Stent Retriever System
- North America
- Asia Pacific
- Rest of the World
To Buy This Report:
- Market size estimation of the Global Neurovascular Intervention market on a regional and global basis
- The unique research design for market size estimation and forecast
- Profiling of major companies operating in the market with key developments
- Broad scope to cover all the possible segments helping every stakeholder in the market
We provide customization of the study to meet specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
For more information, contact: [email protected]